98%
921
2 minutes
20
Proliferating cell nuclear antigen (PCNA) is a central scaffold in eukaryotic DNA replication, repair, and epigenetic regulation. While its roles are well-characterized in canonical model organisms, ciliates, unicellular eukaryotes with nuclear dimorphism and programmed genome remodeling, offer unparalleled insights into PCNA's functional adaptability. Their unique biology, including replication-coupled DNA elimination, macronuclear amplification, and replication band dynamics, positions PCNA at the intersection of genome stability and plasticity. This review systematically compares ciliate and human PCNA through phylogenetic, structural, and functional analyses. We reveal that ciliate PCNAs, despite ∼50 % sequence divergence from mammals, preserve conserved trimerization interfaces and partner-binding motifs, as validated by AlphaFold3-predicted models of the classical model organism Tetrahymena thermophila and the emerging systems Euplotes eurystomus and Stylonychia lemnae. Functional summaries highlight lineage-specific innovations, including epigenetic regulation, paralog specialization for nuclear differentiation, and replication band assembly. These findings have broader implications for elucidating replication-coupled chromatin dynamics, the adaptive evolution of multiprotein complexes, and the use of non-model organisms such as E. eurystomus and S. lemnae to uncover conserved principles of genome biology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejop.2025.126162 | DOI Listing |
Alzheimers Res Ther
September 2025
Department of Neurology, Saarland University, Kirrberger Straße, 66421, Homburg/Saar, Germany.
Background: Alzheimer's disease (AD) patients and animal models exhibit an altered gut microbiome that is associated with pathological changes in the brain. Intestinal miRNA enters bacteria and regulates bacterial metabolism and proliferation. This study aimed to investigate whether the manipulation of miRNA could alter the gut microbiome and AD pathologies.
View Article and Find Full Text PDFSci China Life Sci
September 2025
State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Labora
Histone arginine methylation by protein arginine methyltransferases (PRMTs) is crucial for transcriptional regulation and is implicated in cancers. Despite their therapeutic potential, some PRMTs present challenges as drug targets due to their context-dependent activities. Here, we demonstrate that hypoxia triggers the rapid condensation of PRMT2, which is essential for its histone H3R8 asymmetric dimethylation (H3R8me2a) activity.
View Article and Find Full Text PDFNat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFNat Aging
September 2025
Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
Beyond their classical functions as redox cofactors, recent fundamental and clinical research has expanded our understanding of the diverse roles of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) in signaling pathways, epigenetic regulation and energy homeostasis. Moreover, NAD and NADP influence numerous diseases as well as the processes of aging, and are emerging as targets for clinical intervention. Here, we summarize safety, bioavailability and efficacy data from NAD-related clinical trials, focusing on aging and neurodegenerative diseases.
View Article and Find Full Text PDFNat Struct Mol Biol
September 2025
Developmental Epigenetics, Department of Biochemistry, University of Oxford, Oxford, UK.
X-chromosome inactivation (XCI) in mammals is orchestrated by the noncoding RNA X-inactive-specific transcript (Xist) that, together with specific interacting proteins, functions in cis to silence an entire X chromosome. Defined sites on Xist RNA carry the N-methyladenosine (mA) modification and perturbation of the mA writer complex has been found to abrogate Xist-mediated gene silencing. However, the relative contribution of mA and its mechanism of action remain unclear.
View Article and Find Full Text PDF